Dosimetric Evaluation and Verification of External Beam 3-D Treatment Plans in Humanoid Phantom Using Thermoluminescent Dosimeters (TLDs)


 Thermoluminescent (Tlds) Dosimeters, anthromorphic phantom, vitro Dosimetry, vivo Dosimetry, Linear accelerator.

How to Cite

Rizwana Siddique, Zaheer Uddin, & Muzaffar Hussain. (2021). Dosimetric Evaluation and Verification of External Beam 3-D Treatment Plans in Humanoid Phantom Using Thermoluminescent Dosimeters (TLDs). Journal of Basic & Applied Sciences, 8(2), 690–695.


Dosimetric Evaluation & Verification Of External Beam 3-D Treatment Plans In Humanoid Phantom have been carried out. In this study male anthromorphic phantom, model no.702 D, manufactured by Atom Ltd has been used. The plan was delivered to phantom and TLD- 100 was placed in cavities to evaluate and verify the dose delivered by implementing 3D treatment plans. TLD 100 was calibrated using SIEMENS PRIMUS PLUS Linear Accelerator with calibrated 6 MV X ray beam. We chose phantom skull, abdomen and pelvis region for making treatment plans and then doses by treatment plans have been verified by TLDs. 4%, 3.5% and 3% variation in the results was found for skull, pelvis and abdomen region respectively which is within the safe limit of accuracy i-e from 3% to 5 %. Before working with TLDs, it has also been found that thermoluminescent dosimeters were showing the linear response and results are reproducible for the dose range from 50 cGy to 200 cGy. This study has been performed at Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN) during the year 2010-2011.


Williams JR, Thwaites DI. Radiotherapy Physics in Practice, 1st ed. Oxford: Oxford Medical Publications 1994.

Product Support Guide and Design Specification, [

McCullough E, Krueger A. ‘Performance evaluation of computerized treatment planning systems for radiotherapy: External photon beams. Int J Radiat Oncol Biol Phys 1980; 1599-605.

Absorbed Dose Determination in External BeamRadiotherapy: [

Faiz MK, Roger AP. Treatment Planning in Radiation Oncology. 1st ed. Lippincott Williams & Wilkins 1998.

CIRS Tissue Simulation & Phantom Technology, [

Constantinou C. Phantom materials for radiation dosimetry. I. Liquids and gels. Br J Radiol 1982; 55: 217-24.

Tissue substitutes in Radiation Dosimetry and Measurement, ICRU Report 44 [

CIRS Tissue Simulation & Phantom Technology, USA [

Mayles P, Nahum A, Rosenwald JC. Handbook of Radiotherapy Physics Theory and Practice. 1st ed. Taylor and Francis Group 2007.

Pardhan AS, Bakshi AK. Radiation protection dosimetry, 2002; 98(3): 283.

Bos AJJ. Theory of thermolumenescence. Radiation Measurements 2006; 41.

Cherry P, Duxbury AM. Practical Radiotherapy-Physics and Equipments. 2nd ed. Wiley Blackwell 2009.

Nette HP, Onori S, Fattibene P, Regulla D, Wieser A, Coordinated research efforts for establishing an in international radiotherapy dose intercomparison service based on the alanine/ESR system. App Rad Isotopes 1993; 44(1-2): 7.

Faiz MK. Physics of Radiation Therapy. 4th ed. Lippincott Williams & Wilkins 2010.

Taylor GC, Lilley E. the analysis of thermoluminescent glow peak in LiF(TLD-100). J Phys D 1978; 11(4): 567.

Anacak Y, Arican Z, Bar-Deroma R, Tamira A, Kuten A. Total skin electron irradiation: evaluation of dose uniformity throughout the skin surface. J Med Dos 2003; 28: 31-34.

Delgado A, Gomes Ros JM. Evolution of TLD-100 glow peak IV and V at elevated ambient temperature. J Phys D App Phys 1990; 23(5): 571.

Derreumaux S, Chavaudra J, Bridier A , Rossetti V, Dutreix A. A European quality Assurance network for radiotherapy: dose measurement procedure. Phys Med Biol 1995; 191-208.

Product Support Guide and Design Specification, [

Douglas J. Prescribing, Recording and Reporting Photon Beam Therapy, ICRU Report No. 50 Med Phys 1994; 833.